The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Agent For Use In Treatment Or Prevention Of Ophthalmic Disorders - EP4031117

The patent EP4031117 was granted to Chiesi Farmaceutici on Jul 24, 2024. The application was originally filed on Sep 15, 2020 under application number EP20775227A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4031117

CHIESI FARMACEUTICI
Application Number
EP20775227A
Filing Date
Sep 15, 2020
Status
Granted And Under Opposition
Jun 20, 2024
Publication Date
Jul 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANApr 23, 2025HOFFMANN EITLEADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2018086805
DESCRIPTIONWO0022119
DESCRIPTIONWO2008006893
DESCRIPTIONWO2013092776
DESCRIPTIONWO2016162812
INTERNATIONAL-SEARCH-REPORTWO2008006893
INTERNATIONAL-SEARCH-REPORTWO2013092776
OPPOSITIONUS5272135
OPPOSITIONUS6090781
OPPOSITIONWO2008006893
OPPOSITIONWO2021052926

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents